Literature DB >> 22752721

Genetic typing reveals monomorphism between antimony sensitive and resistant Leishmania donovani isolates from visceral leishmaniasis or post kala-azar dermal leishmaniasis cases in India.

B V Subba Raju1, Srividya Gurumurthy, Katrin Kuhls, Vasundhra Bhandari, Gabriele Schnonian, Poonam Salotra.   

Abstract

Resistance to pentavalent antimonials has emerged as a major hurdle to the treatment and control of visceral leishmaniasis (VL), also known as kala-azar (KA), caused by Leishmania donovani. In India, over 60% of KA patients are unresponsive to the first-line drug sodium antimony gluconate (SAG). Resistance determinants in laboratory strains are partly known; however, the mechanism operating in field isolates is not well understood. In this study, we attempted to analyze the genetic polymorphism between SAG sensitive and resistant parasites using a total of 52 L. donovani isolates obtained either from bone marrow of VL patients or from skin lesions of post kala-azar dermal leishmaniasis (PKDL) patients that constitute an important reservoir of parasite. The clinical isolates were analyzed in comparison with L. donovani parasites from reference strains belonging to distinct geographical locations, at internal transcribed spacer 1 region; coding region of gp63 and nine microsatellite repeat regions. Our results demonstrated that both SAG resistant (n = 26) and sensitive (n = 19) Indian isolates, whether causing VL or PKDL, were monomorphic at all the genetic loci tested, unlike the L. donovani in East African or Leishmania infantum in Mediterranean countries where intraspecies variations exist at these loci. Further, the Indian isolates were found closest to the Kenyan isolates of L. donovani on the basis of fragment analysis of microsatellite markers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22752721     DOI: 10.1007/s00436-012-2996-5

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  35 in total

1.  Use of multilocus microsatellite typing (MLMT) for the genetic analysis of Indian isolates of Leishmania donovani.

Authors:  S Thakur; S Singh; S T Pasha; D S Rawat; S Lal; V Mittal
Journal:  Ann Trop Med Parasitol       Date:  2009-07

2.  Microsatellite analysis reveals genetic structure of Leishmania tropica.

Authors:  Jan M Schwenkenbecher; Thierry Wirth; Lionel F Schnur; Charles L Jaffe; Henk Schallig; Amer Al-Jawabreh; Omar Hamarsheh; Kifaya Azmi; Francine Pratlong; Gabriele Schönian
Journal:  Int J Parasitol       Date:  2005-10-14       Impact factor: 3.981

3.  Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.

Authors:  R Lira; S Sundar; A Makharia; R Kenney; A Gam; E Saraiva; D Sacks
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

4.  Leishmania donovani: intraspecific polymorphisms of Sudanese isolates revealed by PCR-based analyses and DNA sequencing.

Authors:  N O El Tai; M El Fari; I Mauricio; M A Miles; L Oskam; S H El Safi; W H Presber; G Schönian
Journal:  Exp Parasitol       Date:  2001-01       Impact factor: 2.011

5.  Genetic typing and phylogeny of the Leishmania donovani complex by restriction analysis of PCR amplified gp63 intergenic regions.

Authors:  I L Mauricio; M W Gaunt; J R Stothard; M A Miles
Journal:  Parasitology       Date:  2001-04       Impact factor: 3.234

6.  Overexpression of histone H2A modulates drug susceptibility in Leishmania parasites.

Authors:  Ruchi Singh; Dhiraj Kumar; Robert C Duncan; Hira L Nakhasi; Poonam Salotra
Journal:  Int J Antimicrob Agents       Date:  2010-04-27       Impact factor: 5.283

7.  Gp63 gene polymorphism and population structure of Leishmania donovani complex: influence of the host selection pressure?

Authors:  S Guerbouj; K Victoir; I Guizani; N Seridi; N Nuwayri-Salti; M Belkaid; R B Ismail; D Le Ray; J C Dujardin
Journal:  Parasitology       Date:  2001-01       Impact factor: 3.234

8.  Multilocus microsatellite typing (MLMT) reveals genetic homogeneity of Leishmania donovani strains in the Indian subcontinent.

Authors:  Mohammad Zahangir Alam; Katrin Kuhls; Carola Schweynoch; Shyam Sundar; Suman Rijal; Abul Khair M Shamsuzzaman; Balaraju Venkata Subba Raju; Poonam Salotra; Jean-Claude Dujardin; Gabriele Schönian
Journal:  Infect Genet Evol       Date:  2008-10-08       Impact factor: 3.342

9.  High resolution of human evolutionary trees with polymorphic microsatellites.

Authors:  A M Bowcock; A Ruiz-Linares; J Tomfohrde; E Minch; J R Kidd; L L Cavalli-Sforza
Journal:  Nature       Date:  1994-03-31       Impact factor: 49.962

10.  Differentiation and gene flow among European populations of Leishmania infantum MON-1.

Authors:  Katrin Kuhls; Carmen Chicharro; Carmen Cañavate; Sofia Cortes; Lenea Campino; Christos Haralambous; Ketty Soteriadou; Francine Pratlong; Jean-Pierre Dedet; Isabel Mauricio; Michael Miles; Matthias Schaar; Sebastian Ochsenreither; Oliver A Radtke; Gabriele Schönian
Journal:  PLoS Negl Trop Dis       Date:  2008-07-09
View more
  4 in total

1.  Population structures of Leishmania infantum and Leishmania tropica the causative agents of kala-azar in Southwest Iran.

Authors:  Mohammad Amin Ghatee; Hossein Mirhendi; Mehdi Karamian; Walter R Taylor; Iraj Sharifi; Massood Hosseinzadeh; Zahra Kanannejad
Journal:  Parasitol Res       Date:  2018-08-13       Impact factor: 2.289

Review 2.  Multilocus microsatellite typing of Leishmania and clinical applications: a review.

Authors:  Srikanth Aluru; Mallorie Hide; Gregory Michel; Anne-Laure Bañuls; Pierre Marty; Christelle Pomares
Journal:  Parasite       Date:  2015-05-05       Impact factor: 3.000

Review 3.  The immunology of post-kala-azar dermal leishmaniasis (PKDL).

Authors:  Eduard E Zijlstra
Journal:  Parasit Vectors       Date:  2016-08-23       Impact factor: 3.876

4.  Treatment-based strategy for the management of post-kala-azar dermal leishmaniasis patients in the Sudan.

Authors:  A M Musa; E A G Khalil; B M Younis; M E E Elfaki; M Y Elamin; A O A Adam; H A A Mohamed; M M M Dafalla; A A Abuzaid; A M El-Hassan
Journal:  J Trop Med       Date:  2013-04-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.